High Serum Osmolality May Predict the Disease Severity in Patients with Acute Ulcerative Colitis
Abstract
Keywords
Kaynakça
- 1. Dulai PS, Jairath V. Acute severe ulcerative colitis: latest evidence and therapeutic implications. Ther Adv Chronic Dis. 2018;9(2):65-72.
- 2. Danese S, Banerjee R, Cummings JF et al. Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach. Intest Res. 2018;16(4):522-528.
- 3. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J. 1954;2:375-378.
- 4. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571-607.
- 5. Brown SR, Haboubi N, Hampton J, George B, Travis SP. ACPGBI. The management of acute severe colitis: ACPGBI position statement. Colorectal Dis. 2008;10(Suppl 3):8-29.
- 6. Jain S, Kedia S, Bopanna S. et al. Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study. Intest Res. 2018;16(1):69-74.
- 7. Vaduganathan M, Marti CN, Mentz RJ, Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. Am J Cardiol. 2016;117(7):1144-1150.
- 8. Liamis G, Filippatos TD, Liontos A, Elisaf M1. Serum osmolal gap in clinical practice: usefulness and limitations. Postgrad Med. 2017;129(4):456-459.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Aslı Vural
0000-0003-4506-916X
Türkiye
Selahattin Vural
Bu kişi benim
0000-0003-4506-916X
Türkiye
Selim Turfan
0000-0003-4506-916X
Türkiye
Ahmet Cumhur Dülger
Bu kişi benim
0000-0003-4506-916X
Türkiye
Yayımlanma Tarihi
30 Haziran 2020
Gönderilme Tarihi
9 Ocak 2019
Kabul Tarihi
18 Mart 2019
Yayımlandığı Sayı
Yıl 2020 Cilt: 5 Sayı: 2